Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06562153

fMRI Accelerated TMS Depression

Tracking Brain Imaging Changes in Depression Over Clinical Accelerated Transcranial Magnetic Stimulation (TMS) Therapy at the Individual Level

Status
Recruiting
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate whether phenotypic-related brain states revealed by a novel INSCAPE ("Individualized Network-based Single-frame Coactivation Pattern Estimation") neuroimaging method in Major Depressive Disorder (MDD) patients can track brain recovery of MDD patients over an accelerated antidepressant transcranial magnetic stimulation (TMS) treatment.

Detailed description

The aim of this study is to use magnetic resonance imaging (MRI) to capture images of participants' brains and apply an image processing method called INSCAPE to assess brain states. This study will recruit participants who are scheduled to receive accelerated Transcranial Magnetic Stimulation (TMS) therapy for Major Depressive Disorder (MDD). Participation in this study involves two visits, each including a 30-minute MRI scan. The interval between each visit is about one week. Depressed participants will also complete mood assessments at various intervals while they are receiving accelerated TMS for depression.

Conditions

Interventions

TypeNameDescription
OTHERNeuroimaging with Magnetic Resonance Imaging (MRI)MRI will be used to observe brain states over time.

Timeline

Start date
2024-09-23
Primary completion
2026-08-05
Completion
2026-08-05
First posted
2024-08-20
Last updated
2025-10-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06562153. Inclusion in this directory is not an endorsement.